Synergy CHC Earnings Call Transcripts
Fiscal Year 2025
-
2025 saw revenue decline due to a terminated international license and several one-time charges, but strategic progress was made with a new Mexican subsidiary and strong early 2026 beverage sales. Gross margin is expected to stabilize, with growth initiatives focused on Mexico and beverages.
-
Q3 2025 saw double-digit revenue growth, higher gross margins, and continued profitability, supported by new leadership, expanded distribution, and a successful equity raise. Beverage and supplement segments both advanced, with major retail launches planned for 2026.
-
Profitability continued for a 10th straight quarter, with net income up 125% and EPS up 86% year-over-year. Major distribution wins and international expansion are expected to drive further growth, while debt refinancing has improved financial flexibility.
-
The meeting followed a set agenda, with a quorum established and all proposals—including director elections, auditor ratification, equity plan amendment, and preferred stock authorization—approved by shareholders. Final voting results will be filed with the SEC.
-
Q1 2025 saw a 30% EPS increase and expanded EBITDA margin despite a 13% revenue decline, driven by cost control and international expansion. RTD beverage growth and licensing deals are set to boost future revenue, with debt refinancing expected to improve cash flow.
Fiscal Year 2024
-
Eighth consecutive profitable quarter achieved despite a 19% annual revenue decline, impacted by Focus Factor rebranding and retailer de-inventorying. Adjusted EBITDA rose 21% for the year, and new product launches and expanded distribution are expected to drive growth in 2025.
-
Q3 revenue and EBITDA declined year-over-year due to a one-time rebranding and retailer de-inventoring, but profitability was maintained. Expanded retail partnerships and IPO proceeds strengthened the balance sheet, with growth expected to resume in 2025.